Start your Trading & Investing Journey with us
Join our channel for Daily Free Trades with Live analysis on Youtube, Trade Setup with Important Levels, and Important Stock Market Updates
Nephrocare Health Services IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details
Nephrocare Health Services Limited IPO : Key Performance Indicators, PE Ratio, EPS, ROE, ROCE & RoNW
The Company Key Performance Indicates the pre-issue EPS of ₹8.01 and post-issue EPS of ₹6.69 for FY25. The pre-issue P/E ratio is 57.43x,while the post-issue P/E ratio is 68.79x against the Industry P/E ratio is 75.38x The company's ROE for FY25 is 13.45% and RoNW is 13.19% The Annualised EPS is ₹2.84x and P/E is 162.19x. These metrics suggest that the IPO is Fully priced.
Key Performance Indicator
| KPI | Values |
|---|---|
| EPS Pre IPO (Rs.) | 8.01 |
| EPS Post IPO (Rs.) | 6.69 |
| Adjusted 12M EPS Post IPO (Rs.) | 2.84 |
| P/E Pre IPO | 57.43 |
| P/E Post IPO | 68.79 |
| Adjusted 12M P/E Post IPO | 162.19 |
| ROE | 13.45% |
| ROCE | 18.67% |
| P/BV | 7.72 |
| Debt/Equity | 0.45 |
| RoNW | 13.19% |
| EBITDA Margin | 22.05% |
| PAT Margin | 8.71% |
© 2022 CA Abhay Varn. All Rights Reserved Abhayvarn.com
